These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33160373)

  • 1. Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism.
    Zhang M; Liu Q; Zhang M; Cao C; Liu X; Zhang M; Li G; Xu C; Zhang X
    J Nanobiotechnology; 2020 Nov; 18(1):161. PubMed ID: 33160373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer.
    Hong SS; Zhang MX; Zhang M; Yu Y; Chen J; Zhang XY; Xu CJ
    Drug Deliv; 2018 Nov; 25(1):576-584. PubMed ID: 29461120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.
    Zhang M; Zhang M; Wang J; Cai Q; Zhao R; Yu Y; Tai H; Zhang X; Xu C
    Drug Deliv; 2018 Nov; 25(1):995-1003. PubMed ID: 29667478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
    He R; Liu H
    Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
    Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
    Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
    Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
    Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
    [No Abstract]   [Full Text] [Related]  

  • 9. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.
    Zhang MX; Hong SS; Cai QQ; Zhang M; Chen J; Zhang XY; Xu CJ
    Drug Deliv; 2018 Nov; 25(1):797-806. PubMed ID: 29542355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
    Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euxanthone inhibits glycolysis and triggers mitochondria-mediated apoptosis by targeting hexokinase 2 in epithelial ovarian cancer.
    Zou J; Wang Y; Liu M; Huang X; Zheng W; Gao Q; Wang H
    Cell Biochem Funct; 2018 Aug; 36(6):303-311. PubMed ID: 29984416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
    Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway.
    Li Y; Kang J; Fu J; Luo H; Liu Y; Li Y; Sun L
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81-95 peptide show effective antitumor activity against ovarian carcinoma.
    Zhang X; Chen J; Kang Y; Hong S; Zheng Y; Sun H; Xu C
    Int J Pharm; 2013 Sep; 453(2):498-505. PubMed ID: 23811008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
    Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
    Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
    Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anthraquinone derivative KA-4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin.
    Zhao Y; Li X; Xu S; Yang Y; Chen Q; Li J; Tian W; Zhang Q; Hou H; Li D
    Mol Carcinog; 2024 Nov; 63(11):2090-2102. PubMed ID: 39092774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.